Literature DB >> 23353055

TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway.

Xiaojing Meng1, Chunqing Cai, Jiguo Wu, Shaoxi Cai, Changsheng Ye, Haiyang Chen, Zhengduo Yang, Hongqiang Zeng, Qiang Shen, Fei Zou.   

Abstract

Metastasis is an inherent feature of breast cancer and transient receptor potential (TRP) channels were found to be potentially implicated in this process. Particularly, TRPM7 may regulate cell motility. We therefore examined the expression of TRPM7 mRNA in the Oncomine database and found that TRPM7 is correlated to metastasis and invasive breast cancer. Silencing TRPM7 with RNA interference resulted in a significant decrease in migration and invasion capability of MDA-MB-435 breast cancer cells, and phosphorylation levels of Src and MAPK but not AKT. Our results suggest that TRPM7 regulates migration and invasion of metastatic breast cancer cells via MAPK pathway.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23353055     DOI: 10.1016/j.canlet.2013.01.031

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  58 in total

Review 1.  Role of TRP ion channels in cancer and tumorigenesis.

Authors:  George Shapovalov; Abigael Ritaine; Roman Skryma; Natalia Prevarskaya
Journal:  Semin Immunopathol       Date:  2016-02-03       Impact factor: 9.623

2.  Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.

Authors:  Tian-Dong Leng; Ming-Hua Li; Jian-Feng Shen; Ming-Li Liu; Xin-Bo Li; Hua-Wei Sun; Debbie Branigan; Zhao Zeng; Hong-Fang Si; Jun Li; Jeff Chen; Zhi-Gang Xiong
Journal:  CNS Neurosci Ther       Date:  2014-12-01       Impact factor: 5.243

Review 3.  TRPM2 in Cancer.

Authors:  Barbara A Miller
Journal:  Cell Calcium       Date:  2019-03-06       Impact factor: 6.817

4.  Activation of TRPM7 channels by small molecules under physiological conditions.

Authors:  T Hofmann; S Schäfer; M Linseisen; L Sytik; T Gudermann; V Chubanov
Journal:  Pflugers Arch       Date:  2014-03-15       Impact factor: 3.657

Review 5.  TRPM7.

Authors:  Andrea Fleig; Vladimir Chubanov
Journal:  Handb Exp Pharmacol       Date:  2014

6.  Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination.

Authors:  Bridgid E Hast; Erica W Cloer; Dennis Goldfarb; Heng Li; Priscila F Siesser; Feng Yan; Vonn Walter; Ning Zheng; D Neil Hayes; Michael B Major
Journal:  Cancer Res       Date:  2013-12-09       Impact factor: 12.701

Review 7.  Proton-sensitive cation channels and ion exchangers in ischemic brain injury: new therapeutic targets for stroke?

Authors:  Tiandong Leng; Yejie Shi; Zhi-Gang Xiong; Dandan Sun
Journal:  Prog Neurobiol       Date:  2014-01-24       Impact factor: 11.685

8.  Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis.

Authors:  Yi Qin; Zhi-Wei Liao; Jing-Yan Luo; Wen-Zhe Wu; An-Shang Lu; Pu-Xia Su; Bing-Quan Lai; Xiao-Xiao Wang
Journal:  Tumour Biol       Date:  2016-01-15

Review 9.  TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration.

Authors:  N Nielsen; O Lindemann; A Schwab
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

10.  Mibefradil represents a new class of benzimidazole TRPM7 channel agonists.

Authors:  Sebastian Schäfer; Silvia Ferioli; Thomas Hofmann; Susanna Zierler; Thomas Gudermann; Vladimir Chubanov
Journal:  Pflugers Arch       Date:  2015-12-16       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.